Cabazitaxel in Combination With Prednisolone With Primary Prophylaxis With PEG-G-CSF for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Cabazitaxel (Primary) ; Dexamethasone; Dexchlorpheniramine; Diphenhydramine; Granisetron; Metoclopramide; Ondansetron; Pegfilgrastim; Prednisolone; Ranitidine
- Indications Prostate cancer
- Focus Adverse reactions
- Acronyms PEGAZUS
- Sponsors Sanofi
- 07 Jun 2017 Biomarkers information updated
- 23 Jan 2017 Status changed from active, no longer recruiting to completed.
- 29 Mar 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.